Central nervous system stimulants

Bailliere's Best Practice and Research in Clinical Endocrinology and Metabolism

Volumn 14, Issue 1, 2000, Pages 79-88

  George, Alan J ^a  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Amphetamine; Caffeine; Cocaine; Sporting performance; Stimulants

Indexed keywords

AMPHETAMINE; CAFFEINE; CENTRAL STIMULANT AGENT; COCAINE; DOPAMINE; FATTY ACID; GLUCOSE; NEUROTRANSMITTER;

ANAEROBIC METABOLISM; CARDIOTOXICITY; DOPING; DRUG ABUSE; ENERGY METABOLISM; FATTY ACID METABOLISM; HUMAN; NEUROPHYSIOLOGY; PHYSICAL PERFORMANCE; PSYCHOSIS; REVIEW;

EID: 0033944585     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1053/beem.2000.0055     Document Type: Article

References (27)

1. George A J. CNS stimulants. Mottram D R. Drugs in Sport. 1996;86-112 E. and F. Spon, London.
2. Brookes L G. Central nervous system stimulants. Iverson S D. Psychopharmacology: Recent Advances and Future Prospects. 1985;264-277 Oxford University Press, Oxford.
3. Seiden L S, Sabol K E, Ricaurte G A. Amphetamine: effects on catecholamine systems and behaviour. Annual Review of Pharmacology and Toxicology. 32:1993;639-677.
4. Silverstone T, Goodall E. How amphetamine works. Iverson S D. Psychopharmacology: Recent Advances and Future Prospects. 1985;315-325 Oxford University Press, Oxford.
5. Connell P H. Amphetamine Psychosis. 1958;Chapman and Hall, London.
6. Smith G M, Beecher H G. Amphetamine sulphate and athletic performance. Journal of the American Medical Association. 170:1959;542-551.
7. Wyndham G H, Rogers G G, Bendade A JS, Strydan N B. Physiological effects of the amphetamines during exercise. South African Medical Journal. 45:1971;247-252.
8. Wadler G A, Hainline B. Drugs and the athlete. 1989;F.A. Davies Company, Philadelphia.
9. Conlee R K. Amphetamine, caffeine and cocaine. Lamb D R, Williams M H. Perspectives in Exercise Science and Sports Medicine. 1991;285-328 Brown and Benchmark, New York.
10. Mandell A J. The Sunday syndrome: a unique pattern of amphetamine abuse indigenous to American professional football. Clinical Toxicology. 15:1979;225-232.
11. Mandell A J, Stewart K D, Russo P V. The Sunday syndrome from kinetics to altered consciousness. Federation Proceedings. 40:1981;2693-2696.
12. Laties V G, Weiss B. The amphetamine margin in sports. Federation Proceedings. 40:1981;2689-2692.
13. Sawynok J, Yaksh T L. Caffeine as an analgesic adjuvant. A review of pharmacology and mechanisms of action. Pharmacological Reviews. 45:1993;43-85.
14. Lelo A, Miners J O, Robson R, Birkett D J. Assessment of caffeine exposure: caffeine content of beverages, caffeine intake and plasma concentrations of methyl xanthines. Clinical Pharmacology and Therapeutics. 39:1986;54-59.
15. Daly J W, Butts P, Lamb P, Padgett W. Sub-classes of adenosine receptors in the central nervous system interaction with caffeine and related methyl xanthines. Cellular and Molecular Neurobiology. 3:1983;69-80.
16. Greden J F. Anxiety of caffeinism: a diagnostic dilemma. American Journal of Psychiatry. 131:1974;1089-1092.
17. Diagnostic and Statistical Manual of Mental Disorders. 1998;American Psychiatric Press, Washington.
18. Bellet S, Kershbaum A, Aspe J. The effect of caffeine on free fatty acids. Archives of Internal Medicine. 116:1965;750-752.
19. Costill D L, Dalsky G P, Fink W J. Effects of caffeine ingestion on metabolism and exercise performance. Medicine and Science in Sports. 10:1978;155-158.
20. Dodd S L, Herb R A, Power S K. Caffeine and exercise performance - an update. Sports Medicine. 15:1993;14-23.
21. Ivy J L, Costill D L, Fink W J. Influence of caffeine and carbohydrate feedings on endurance performance. Medicine and Science in Sports. 11:1979;6-11.
22. Fibiger H C, Phillips A G, Brown E E. The neurobiology of cocaine-induced reinforcement. Wolstenholme G EW. Cocaine: Scientific and Social Dimensions. 1992;64-80 John Wiley, Chichester.
23. Kuhar M J. Molecular pharmacology of cocaine: a dopamine hypothesis and its implications. Wolstenholme G EW. Cocaine: Scientific and Social Dimensions. 1992;81-95 John Wiley, Chichester.
24. Smith D A, Perry P J. The efficacy of ergogenic agents in athletic competition. Part II: other performance-enhancing agents. Annals of Pharmacotherapy. 26:1992;653-659.
25. Conlee R K, Han D H, Kelly K P, Barnett D W. Effects of cocaine on plasma catecholamine and muscle glycogen concentrations during exercise in the rat. Journal of Applied Physiology. 70:1991;1323-1327.
26. Cantwell J D, Rose F D. Cocaine and cardiovascular events. Physician and Sports Medicine. 14:1981;77-82.
27. Welder A A, Melchert R B. Cardiotoxic effects of cocaine and anabolic-androgenic steroids in the athlete. Journal of Pharmacological and Toxicological Methods. 29:1993;61-68.